GlassScriptPhysician profile
Eunyoung Kim
NPI 1619150448
$943.40
in general payments reported to CMS, 2019-2025
8 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.16 · 2022: $89.50 · 2023: $121 · 2024: $319 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $710.97 | 2021-2025 | Pipeline, Solitaire X, Onyx 18 |
| Penumbra, INC. | $97.85 | 2024 | Indigo System |
| Abiomed | $43.61 | 2025 | |
| Janssen Biotech, INC. | $20.20 | 2025 | Talvey |
| Gilead Sciences, INC. | $19.69 | 2023 | |
| Genentech USA, INC. | $19.33 | 2023 | Lunsumio, Polivy, Columvi |
| Alexion Pharmaceuticals, INC. | $16.52 | 2025 | Ultomiris |
| Incyte Corporation | $15.23 | 2023 | Opzelura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunyoung Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.